← Back to search

Lavo Life Sciences

AI for drug formulation

Y CombinatorWinter 2023InactiveHealthcareDrug Discovery and DeliveryAI-powered Drug DiscoveryMachine LearningBiotechDrug discovery

What they do

Problem

Drug formulation and development is slow, expensive, and risky because selecting effective molecule formulations requires extensive lab experimentation.

Solution

It provides AI-driven computational simulations of drug molecules to guide formulation experiments and accelerate development and approval.

Who it's for

Pharmaceutical companies and drug development teams use it to inform and prioritize lab experiments.

Founders

Scott Swarthout
Founder

CEO of Lavo Life Sciences

Zach Glick
Founder
Derek Metcalf
Founder

Company timeline

Similar startups